BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced Tuesday that the U.S. Food and Drug Administration has approved its epinephrine injection USP in both single-dose and ...

An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.

Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...

Results suggest real-world effectiveness of neffy is consistent with that historically reported for epinephrine injection Figure 1: Treatment success rate with a single dose of neffy administered by a ...

Investing.com -- Amneal Pharmaceuticals Inc Class A (NASDAQ:AMRX) stock rose 2.8% in after-hours trading Tuesday following the FDA approval of the company’s epinephrine injection USP, expanding its ...

BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Amneal said that the Food and Drug Administration has approved its epinephrine injection in both single and multi-dose vials for hospitals. The Bridgewater, NJ-based biopharmaceutical company said ...

MALVERN, Pa., Sept. 23, 2025 /PRNewswire/ -- Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of ADRENALIN ® (epinephrine in 0.9% sodium chloride injection) premixed IV ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of epinephrine injection USP, 30 mg/30 mL (1 mg/mL) multiple-dose vial. Glenmark’s epinephrine injection USP, 30 mg/30 mL (1 mg/mL) ...